High Power Short Duration Ablation Compared to Moderate Power Long Duration Ablation for Pulmonary Vein Isolation
NCT ID: NCT05959798
Last Updated: 2023-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
204 participants
OBSERVATIONAL
2019-04-20
2023-07-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Results of Bilateral Thoracoscopic Ablation for Stand-alone Atrial Fibrillation
NCT05836389
Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation
NCT01229306
Clinical and Electrophysiological Predictors of Arrhythmic Recurrence in Patients With Paroxysmal AF Undergoing First Ablation Procedure of AF by Pulmonary Vein Isolation
NCT06085014
High Power vs Standard Power RF Ablation of Atrial Fibrillation in Conscious Patients
NCT04250181
Durability of Pulmonary Vein Isolation Following Cryoablation for Treatment of Paroxysmal Atrial Fibrillation
NCT01645917
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High power short duration ablation
High power short duration ablation
Pulmonary vein isolation by high power short duration radiofrequency catheter ablation
Moderate power long duration ablation
High power short duration ablation
Pulmonary vein isolation by high power short duration radiofrequency catheter ablation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High power short duration ablation
Pulmonary vein isolation by high power short duration radiofrequency catheter ablation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* effective oral anticoagulation
Exclusion Criteria
* presence of left atrial thrombus
* secondary atrial fibrillation due to electrolyte imbalance or thyroid disease
* any prior oesophageal or gastric surgery
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Deutsches Herzzentrum Muenchen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabel Deisenhofer, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Deutsches Herzzentrum München, Abt. für Elektrophysiologie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Deutsches Herzzentrum München
München, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
POWER PULSE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.